Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Filings today ..

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Jan 15, 2021 8:57pm

320 Views

Post# 32312190

RE:Filings today ..

For whatever reason I find this easier to read:

As of 11:59pm ET January 15th, 2021

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value
Jan 15/21	Jan 11/21	Wilson, Alain	Control or Direction	Restricted Share Units	56 - Grant of rights	124,700
Jan 15/21	Jan 11/21	Wallace, John Lawrence	Direct Ownership	Restricted Share Units	56 - Grant of rights	484,200
Jan 15/21	Jan 11/21	Vaughan, David James	Direct Ownership	Restricted Share Units	56 - Grant of rights	102,700
Jan 15/21	Jan 11/21	Stauffer, Joseph	Direct Ownership	Restricted Share Units	56 - Grant of rights	70,000
Jan 15/21	Jan 11/21	Macnee, Walter Minnes	Direct Ownership	Restricted Share Units	56 - Grant of rights	40,000
Jan 15/21	Jan 11/21	Legault, Daniel Marcel	Direct Ownership	Restricted Share Units	56 - Grant of rights	513,200
Jan 15/21	Jan 11/21	Khouri, Amal	Direct Ownership	Restricted Share Units	56 - Grant of rights	40,000
Jan 15/21	Jan 11/21	Flower, Roderick John	Direct Ownership	Restricted Share Units	56 - Grant of rights	40,000
Jan 15/21	Jan 11/21	Curtis, Scott Wilson	Direct Ownership	Restricted Share Units	56 - Grant of rights	102,700
Jan 15/21	Jan 11/21	Batal, Rami	Direct Ownership	Restricted Share Units	56 - Grant of rights	64,500